Sort
48,018 grants matching “immunotherapy”
OVARIAN CANCER IMMUNOTHERAPY USING REDIRECTED ENDOGENOUS ANTI-GAL ANTIBODY
$598,604University Of Wisconsin System · · FY2008 · Department of the Army
FETAL IMMUNOPROPHYLAXIS AGAINST A PRIMATE LENTIVIRUS
$598,540Dana-Farber Cancer Institute · R01 · FY2001 · AI
Developing Tolerance Approaches to Overcome Humoral Immunity
$598,463Stuart Johnston Knechtle · Emory University · U19 · FY2014 · AI
Novel IL-15 Superagonist Therapy for Bladder Cancer
$598,323Hing C. Wong · Altor Bioscience. Llc · R44 · FY2014 · CA
Novel IL-15 Superagonist Therapy for Bladder Cancer
$598,323Hing C. Wong · Altor Bioscience. Llc · R44 · FY2015 · CA
Defining the four major routes of MHC class II antigen processing and presentation with influenza antigens
$598,313Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2025 · AI
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$598,289Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2020 · NS
UW SPECT/CT Acquisition
$598,202Jamey P Weichert · University Of Wisconsin-Madison · S10 · FY2020 · OD
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation
$598,126Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2025 · CA
Compositions and methods for enhanced fluorine-19 magnetic resonance imaging cell tracking
$598,045Eric T Ahrens · University Of California, San Diego · R01 · FY2019 · EB
Compositions and methods for enhanced fluorine-19 magnetic resonance imaging cell tracking
$598,045Eric T Ahrens · University Of California, San Diego · R01 · FY2017 · EB
Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of âstem-likeâ CAR-T cells
$598,044Shivani Srivastava · Fred Hutchinson Cancer Center · R37 · FY2025 · CA
Multiphoton microscopy for in vivo neural imaging
$598,020Brian J Bacskai · Massachusetts General Hospital · R56 · FY2019 · AG
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer
$597,876Maximilian Diehn · Stanford University · R01 · FY2024 · CA
Shared Resource Management
$597,844Nicholas P Ambulos · University Of Maryland Baltimore · P30 · FY2023 · CA
Shared Resource Management
$597,844Nicholas P Ambulos · University Of Maryland Baltimore · P30 · FY2022 · CA
Shared Resource Management
$597,844Nicholas P Ambulos · University Of Maryland Baltimore · P30 · FY2024 · CA
Shared Resource Management
$597,844Nicholas P Ambulos · University Of Maryland Baltimore · P30 · FY2021 · CA
Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
$597,835Keith W. Kelley · University Of Illinois At Urbana-Champaign · R01 · FY2011 · AG
Role of T Cell Immunity in Primate AIDS
$597,772Emory University · R01 · FY2004 · AI
Epigenomic Mechanisms & Contextual Immunity in Persistent MRSA Bacteremia
$597,740Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2025 · AI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$597,694Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
CAREER: Multimodal Biomaterials for Sequential Delivery of Diverse Immunotherapeutic Cargos
$597,638Thomas A Werfel · University Of Mississippi · · FY2022 · MPS
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles
$597,571Elias Sayour · University Of Florida · R01 · FY2024 · CA
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.
$597,570Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2024 · NS